Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.47 - $2.22 $6,027 - $9,102
-4,100 Reduced 5.73%
67,480 $130,000
Q2 2023

Aug 15, 2023

BUY
$3.16 - $4.96 $22,688 - $35,612
7,180 Added 11.15%
71,580 $305,000
Q4 2022

Feb 14, 2023

BUY
$5.03 - $8.58 $31,186 - $53,196
6,200 Added 10.65%
64,400 $373,000
Q2 2022

Aug 15, 2022

BUY
$6.72 - $16.07 $29,568 - $70,708
4,400 Added 8.18%
58,200 $521,000
Q1 2022

May 13, 2022

BUY
$11.88 - $23.4 $1,188 - $2,340
100 Added 0.19%
53,800 $820,000
Q3 2021

Nov 10, 2021

BUY
$27.67 - $45.04 $511,895 - $833,240
18,500 Added 52.56%
53,700 $1.85 Million
Q2 2021

Jul 30, 2021

BUY
$28.75 - $56.92 $833,750 - $1.65 Million
29,000 Added 467.74%
35,200 $1.15 Million
Q1 2021

May 06, 2021

BUY
$38.67 - $84.06 $239,754 - $521,172
6,200 New
6,200 $310,000

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $115M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.